feed,title,long_url,short_url
SeekingAlpha,Regeneron downgraded at Bernstein on risk to Eylea outlook,https://seekingalpha.com/news/3780392,
SeekingAlpha,Nektar Therapeutics reports phase 1b data for NKTR-358 study in atopic dermatitis,https://seekingalpha.com/news/3780391,
